| http://www.w3.org/ns/prov#value | - The present invention is based on the realisation that targeting the discreet pro-survival functions of NF-??B in cell survival via Gadd45?? provides safer, more effective, therapy than does targeting NF-??B directly for a range of diseases and disorders including cancer and also other diseases characterised by aberrant cell survival or diseases which could be treated by the induction of increased
|
